How to take advantage of easily available biomarkers in patients with IgA nephropathy: IgA and C3 in serum and kidney biopsies
Crossref DOI link: https://doi.org/10.1007/s00467-022-05644-9
Published Online: 2022-08-02
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mizerska-Wasiak, MaĆgorzata
Text and Data Mining valid from 2022-08-02
Version of Record valid from 2022-08-02
Article History
Received: 4 October 2021
Revised: 3 May 2022
Accepted: 24 May 2022
First Online: 2 August 2022
Declarations
:
: The author declares no competing interests.